Year: 2017
Type: review
Abstract: Age-related macular degeneration (AMD) is the leading cause of irreversible central vision loss in developed countries. With the aging of population, AMD will become globally an increasingly important and prevalent disease worldwide. It is a complex disease whose etiology is associated with both genetic and environmental risk factors. An extensive decline in the quality of life and progressive need of daily living assistance resulting from AMD among those most severely affected highlights the essential role of preventive strategies, particularly advising patients to quit smoking. In addition, maintaining a healthy diet, controlling other risk factors (such as hypertension, obesity, and atherosclerosis), and the use of nutritional supplements (antioxidants) are recommendable. Genetic testing may be especially important in patients with a family history of AMD. Recently, unifying criteria for the clinical classification of AMD, defining no apparent aging changes; normal aging changes; and early, intermediate, and late AMD stages, are of value in predicting AMD risk of progression and in establishing recommendations for the diagnosis, therapeutic approach, and follow-up of patients. The present review is focused on early and intermediate AMD and presents a description of the clinical characteristics and ophthalmological findings for these stages, together with algorithms for the diagnosis and management of patients, which are easily applicable in daily clinical practice.
Source: Clinical Interventions in Aging
DOI: 10.2147/cia.s142685
Institutions: Instituto de Salud Carlos III, Clinica Universidad de Navarra, Sociedad Espaola de retina y Vtreo, Universidad de Las Palmas de Gran Canaria, Hospital Universitario Insular de Gran Canaria, Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari, Instituto de Microcirugía Ocular, Bellvitge University Hospital, Universitat de Barcelona, Miranza, University of Castilla-La Mancha
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: age-related macular degeneration, early AMD, intermediate AMD, AMD risk factors, genetic risk factors, environmental risk factors, smoking cessation, dietary supplements, antioxidants, genetic testing, AMD progression, diagnostic algorithm, management algorithm, central vision loss, quality of life
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W2762494246
